93 results
Page 2 of 5
8-K
EX-10.1
629pkqy7oh5644pzjhs2
21 Feb 20
Adamis Pharmaceuticals Announces Pricing of $6.7 Million Registered Direct Offering
5:24pm
8-K
EX-1.1
ov4jrei6
1 Aug 19
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:16pm
424B5
aysilt4gm79ik
2 Aug 18
Prospectus supplement for primary offering
9:17pm
8-K
EX-1.1
1wzfbcfc3cala5gj42
2 Aug 18
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
9:15am
424B5
s937juns
1 Aug 18
Prospectus supplement for primary offering
4:16pm
10-KT
EX-10.50
9fc239gixj6px64ad sx
26 Mar 15
Annual report (with FYE transition)
12:00am
10-KT
je1n19ul6ou5b
26 Mar 15
Annual report (with FYE transition)
12:00am
8-K
EX-1.1
lgkk9nbqab3p
9 Jan 15
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
12:00am
8-K
EX-10.1
iwlb5fp
20 Aug 14
Adamis Pharmaceuticals Announces Private Placement
12:00am
8-K
EX-1.1
hfverc3jmib
17 Dec 13
Adamis Pharmaceuticals Announces Pricing of Public Offering of 3,720,000
12:00am